Millennium Management
STRO icon

Millennium Management’s Sutro Biopharma STRO Stock Holding History

Millennium Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,460
Closed -$545K – 7480
2022
Q2 		$545K Buy
+10,460
New +$584K ﹤0.01% 4880
2021
Q2 		– Sell
-2,500
Closed -$569K – 7078
2021
Q1 		$569K Buy
+2,500
New +$593K ﹤0.01% 4723

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management's STRO Position: Q1 2026 in Review

Millennium Management reduced its Sutro Biopharma (STRO) stake by 50% in Q1 2026, selling an estimated $3.76M and leaving 210,378 shares worth $5.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2885.

Millennium Management first reported a position in STRO in Q3 2018 and has held it in 30 quarters since. The position peaked at $26.8M in Q1 2024. 78 funds tracked by Wall St. Rank hold STRO as of Q1 2026.

  • Millennium Management held 210,378 shares of Sutro Biopharma worth $5.24M as of Q1 2026.
  • Millennium Management sold 207,818 Sutro Biopharma shares in Q1 2026, an estimated $3.76M.
  • Sutro Biopharma made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2885 holding.
  • Millennium Management first reported a position in Sutro Biopharma in Q3 2018 and has held it in 30 quarters since.
  • Millennium Management's Sutro Biopharma position peaked at $26.8M in Q1 2024.
  • 78 funds tracked by Wall St. Rank held Sutro Biopharma as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.